Myriad Genetics
MYGN
MYGN
219 hedge funds and large institutions have $481M invested in Myriad Genetics in 2025 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 91 increasing their positions, 53 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
219
Holders Change
-9
Holders Change %
-3.95%
% of All Funds
2.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
91
Reduced
53
Closed
49
Calls
$2.45M
Puts
$105K
Net Calls
+$2.35M
Net Calls Change
+$1.66M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$24.2M |
| 2 |
D.E. Shaw & Co
New York
|
$24M |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
$7.15M |
| 4 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
$6.64M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$9.09M |
